Research graph
References from Cryptic amyloidogenic regions in intrinsically disordered proteins: Function and disease association. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1126/science.1219021
10.1126/science.1219021 · External reference
10.1146/annurev-biochem-061516-045115
10.1146/annurev-biochem-061516-045115 · External reference
10.1016/j.sbi.2011.11.007
10.1016/j.sbi.2011.11.007 · External reference
Physicochemical principles that regulate the competition between functional and dysfunctional association of proteins
10.1073/pnas.0812414106 · 2009 · External reference
The seesaw between normal function and protein aggregation: How functional interactions may increase protein solubility
10.1002/bies.202100031 · 2021 · External reference
10.1038/sj.emboj.7601930
10.1038/sj.emboj.7601930 · External reference
10.1101/cshperspect.a033878
10.1101/cshperspect.a033878 · External reference
10.1016/j.jmb.2005.11.035
10.1016/j.jmb.2005.11.035 · External reference
10.1371/journal.pcbi.1002090
10.1371/journal.pcbi.1002090 · External reference
Deciphering the role of the thermodynamic and kinetic stabilities of SH3 domains on their aggregation inside bacteria
10.1002/pmic.201000260 · 2010 · External reference
10.1089/ars.2013.5543
10.1089/ars.2013.5543 · External reference
10.1016/j.celrep.2020.03.076
10.1016/j.celrep.2020.03.076 · External reference
10.1096/fj.10-161208
10.1096/fj.10-161208 · External reference
10.1371/journal.pcbi.1000476
10.1371/journal.pcbi.1000476 · External reference
On the role of aggregation prone regions in protein evolution, stability, and enzymatic catalysis: insights from diverse analyses
10.1371/journal.pcbi.1003291 · 2013 · External reference
Protein aggregation profile of the human kinome
10.3389/fphys.2012.00438 · 2012 · External reference
Structural hot spots for the solubility of globular proteins
10.1038/ncomms10816 · 2016 · External reference
10.1016/j.jmb.2004.06.088
10.1016/j.jmb.2004.06.088 · External reference
10.1016/j.bpj.2016.01.030
10.1016/j.bpj.2016.01.030 · External reference
10.1002/1097-0134(20001115)41:3<415::aid-prot130>3.0.co;2-7
10.1002/1097-0134(20001115)41:3<415::aid-prot130>3.0.co;2-7 · External reference
10.1038/nrm3920
10.1038/nrm3920 · External reference
10.1021/acsnano.8b00417
10.1021/acsnano.8b00417 · External reference
10.1126/science.aan6398
10.1126/science.aan6398 · External reference
10.1038/s41467-020-17207-3
10.1038/s41467-020-17207-3 · External reference
10.1016/j.jmb.2018.05.046
10.1016/j.jmb.2018.05.046 · External reference
10.1016/j.jmb.2012.04.015
10.1016/j.jmb.2012.04.015 · External reference
10.1007/s00018-018-2797-9
10.1007/s00018-018-2797-9 · External reference
10.1002/anie.201605321
10.1002/anie.201605321 · External reference
DisProt: intrinsic protein disorder annotation in 2020
2020 · External reference
10.1093/nar/gky1134
10.1093/nar/gky1134 · External reference
MobiDB-lite 3.0: fast consensus annotation of intrinsic disorder flavours in proteins
2020 · External reference
10.1126/science.1651563
10.1126/science.1651563 · External reference
Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene
1996 · External reference
10.1016/s0002-9440(10)64747-5
10.1016/s0002-9440(10)64747-5 · External reference
Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma
10.1093/hmg/1.8.559 · 1992 · External reference
Genetic inactivation of the APC gene contributes to the malignant progression of sporadic hepatocellular carcinoma: a case report
10.1002/gcc.20362 · 2006 · External reference
10.1126/science.2992089
10.1126/science.2992089 · External reference
Lung cancer: intragenic ERBB2 kinase mutations in tumours
10.1038/431525b · 2004 · External reference
10.1038/sj.onc.1210477
10.1038/sj.onc.1210477 · External reference
10.1038/sj.bjc.6604650
10.1038/sj.bjc.6604650 · External reference
10.1158/1078-0432.ccr-16-2811
10.1158/1078-0432.ccr-16-2811 · External reference
The transcription factor Fos: a Janus-type regulator in health and disease
2009 · External reference
10.1073/pnas.79.24.7824
10.1073/pnas.79.24.7824 · External reference
10.1073/pnas.97.1.228
10.1073/pnas.97.1.228 · External reference
10.1038/nature08822
10.1038/nature08822 · External reference
10.1056/nejm198912213212501
10.1056/nejm198912213212501 · External reference
10.1016/s1535-6108(02)00102-2
10.1016/s1535-6108(02)00102-2 · External reference
Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis
10.1177/1947601911408889 · 2011 · External reference
10.1002/humu.20495
10.1002/humu.20495 · External reference
10.3390/cancers3010994
10.3390/cancers3010994 · External reference
10.1038/nmeth.1432
10.1038/nmeth.1432 · External reference
10.1038/nprot.2008.211
10.1038/nprot.2008.211 · External reference
10.1074/mcp.o111.014704
10.1074/mcp.o111.014704 · External reference
10.1016/j.jmb.2014.09.026
10.1016/j.jmb.2014.09.026 · External reference
10.1093/nar/gky1131
10.1093/nar/gky1131 · External reference
10.1038/nature01891
10.1038/nature01891 · External reference
The in vivo and in vitro aggregation properties of globular proteins correlate with their conformational stability: the SH3 case
10.1016/j.jmb.2008.03.020 · 2008 · External reference
10.1016/j.csbj.2020.05.026
10.1016/j.csbj.2020.05.026 · External reference
Computational prediction and redesign of aberrant protein oligomerization
10.1016/bs.pmbts.2019.11.002 · 2020 · External reference
AGGRESCAN: a server for the prediction and evaluation of “hot spots” of aggregation in polypeptides
10.1186/1471-2105-8-65 · 2007 · External reference
10.1038/nbt1012
10.1038/nbt1012 · External reference
10.1186/1472-6807-5-18
10.1186/1472-6807-5-18 · External reference
10.1006/jmbi.1999.3422
10.1006/jmbi.1999.3422 · External reference
10.1038/nchem.2889
10.1038/nchem.2889 · External reference
Exploring the 'aggregation-prone' core of human Cystatin C: a structural study
10.1016/j.jsb.2015.07.013 · 2015 · External reference
DisProt 7.0: a major update of the database of disordered proteins
10.1093/nar/gkw1056 · 2017 · External reference
What's in a name? Why these proteins are intrinsically disordered: why these proteins are intrinsically disordered
10.4161/idp.24157 · 2013 · External reference
10.1073/pnas.1304749110
10.1073/pnas.1304749110 · External reference
10.15252/embj.2019102864
10.15252/embj.2019102864 · External reference
Assessing the role of aromatic residues in the amyloid aggregation of human muscle acylphosphatase
10.1110/ps.051915806 · 2006 · External reference
Glycine residues appear to be evolutionarily conserved for their ability to inhibit aggregation
10.1016/j.str.2005.04.022 · 2005 · External reference
10.1073/pnas.0915166107
10.1073/pnas.0915166107 · External reference
10.1371/journal.pcbi.1000199
10.1371/journal.pcbi.1000199 · External reference
Protein aggregation profile of the bacterial cytosol
10.1371/journal.pone.0009383 · 2010 · External reference
10.1371/journal.pone.0058297
10.1371/journal.pone.0058297 · External reference
10.1002/iub.1034
10.1002/iub.1034 · External reference
10.1039/c1mb05231d
10.1039/c1mb05231d · External reference
MobiDB: intrinsically disordered proteins in 2021
10.1093/nar/gkaa1058 · 2021 · External reference
10.1073/pnas.1209312109
10.1073/pnas.1209312109 · External reference
10.1038/nprot.2016.010
10.1038/nprot.2016.010 · External reference
Correlation between mRNA expression levels and protein aggregation propensities in subcellular localisations
10.1039/b913099n · 2009 · External reference
10.1073/pnas.1910444117
10.1073/pnas.1910444117 · External reference
10.1002/biot.201100014
10.1002/biot.201100014 · External reference
10.1016/j.tibs.2007.03.005
10.1016/j.tibs.2007.03.005 · External reference
10.1016/j.tips.2014.12.004
10.1016/j.tips.2014.12.004 · External reference
10.1016/j.celrep.2013.09.043
10.1016/j.celrep.2013.09.043 · External reference
A metastable subproteome underlies inclusion formation in muscle proteinopathies
10.1186/s40478-019-0853-9 · 2019 · External reference
10.1073/pnas.1516604113
10.1073/pnas.1516604113 · External reference
10.1186/1471-2164-10-s1-s7
10.1186/1471-2164-10-s1-s7 · External reference
10.1146/annurev.biophys.37.032807.125924
10.1146/annurev.biophys.37.032807.125924 · External reference
P53 dysfunction in neurodegenerative diseases – the cause or effect of pathological changes?
10.14336/ad.2016.1120 · 2017 · External reference
Activation of c-Fos contributes to amyloid beta-peptide-induced neurotoxicity
10.1016/0006-8993(95)01332-6 · 1996 · External reference
10.1111/bpa.12424
10.1111/bpa.12424 · External reference
Calpastatin mediates development of Alzheimer’s disease in diabetes
10.3233/jad-190004 · 2019 · External reference
10.1093/hmg/ddu112
10.1093/hmg/ddu112 · External reference
10.1002/ana.20433
10.1002/ana.20433 · External reference
10.1016/s0022-2836(02)00969-5
10.1016/s0022-2836(02)00969-5 · External reference
10.1038/nchembio.546
10.1038/nchembio.546 · External reference
Direct evidence of cellular transformation by prion-like p53 amyloid infection
10.1242/jcs.258316 · 2021 · External reference
10.1002/path.4872
10.1002/path.4872 · External reference
10.1038/nsmb.3191
10.1038/nsmb.3191 · External reference
The tumor suppressor protein PTEN undergoes amyloid-like aggregation in tumor cells
2020 · External reference
10.1016/j.cell.2005.09.044
10.1016/j.cell.2005.09.044 · External reference
Expression patterns of retinoblastoma protein in Parkinson disease
10.1093/jnen/62.1.68 · 2003 · External reference
10.1038/nrc2723
10.1038/nrc2723 · External reference
10.1038/cdd.2010.35
10.1038/cdd.2010.35 · External reference
10.1101/gad.14.8.981
10.1101/gad.14.8.981 · External reference
10.1186/1471-2164-9-s1-s1
10.1186/1471-2164-9-s1-s1 · External reference
Sequence-specific transcriptional activation is essential for growth suppression by p53
10.1073/pnas.91.6.1998 · 1994 · External reference
10.1038/sj.onc.1204373
10.1038/sj.onc.1204373 · External reference
C-terminal truncated alpha-synuclein fibrils contain strongly twisted beta-sheets
10.1021/jacs.7b07403 · 2017 · External reference
10.1016/s0022-2836(03)00175-x
10.1016/s0022-2836(03)00175-x · External reference
10.1021/bi051192j
10.1021/bi051192j · External reference
P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer's disease
10.1186/s40478-020-01012-6 · 2020 · External reference
10.1016/j.bbrc.2012.11.130
10.1016/j.bbrc.2012.11.130 · External reference
Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer
10.1074/jbc.m112.340638 · 2012 · External reference
